Nitrile Examination Gloves Sources Sought

Value counts new single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling (same contract, or the same office, day and amount); that ceiling is not one company's win, so it is not added in. Contract modifications are not new awards and are not added in either. Notices whose amount is a placeholder such as $999,999,999 are not added in. Revenue next to a ticker is the company's revenue over the latest 12 months in its SEC filings.

• Oct 27, 2026MCKESSON MEDICAL-SURGICAL GOVERNMENT SOLUTIONS LLC$4.4BMSPV GEN VI Contract SPE2DV27D0003 - South PrimaryNo listed company matched (Materiality N/A)
• Oct 27, 2026CONCORDANCE HEALTHCARE SOLUTIONS LLC$730.3MMSPV GEN VI Contract SPE2DV27D0006 - West BackupNo listed company matched (Materiality N/A)
• Oct 27, 2026CARDINAL HEALTH 200, LLC$8.8BMSPV GEN VI Contract SPE2DV27D0001 - North PrimaryMateriality: 3.5% of $CAH revenue (Medium)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. For this company the latest 10-K year is used. Here: $8.8B award ÷ $254.2B revenue, fiscal year ending Jun 30, 2026 (SEC 10-K). SEC
• Oct 27, 2026CONCORDANCE HEALTHCARE SOLUTIONS LLC$982.3MMSPV GEN VI Contract SPE2DV27D0002 - North Back-UpNo listed company matched (Materiality N/A)
• Oct 27, 2026CARDINAL HEALTH 200, LLC$485.4MMSPV GEN VI Contract SPE2DV27D0004 - South BackupMateriality: 0.19% of $CAH revenue (Low)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. For this company the latest 10-K year is used. Here: $485.4M award ÷ $254.2B revenue, fiscal year ending Jun 30, 2026 (SEC 10-K). SEC
• Oct 27, 2026CARDINAL HEALTH 200, LLC$6.6BMSPV GEN VI Contract SPE2DV27D0005 - West PrimaryMateriality: 2.6% of $CAH revenue (Medium)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. For this company the latest 10-K year is used. Here: $6.6B award ÷ $254.2B revenue, fiscal year ending Jun 30, 2026 (SEC 10-K). SEC
• Oct 1, 2026BOSTON SCIENTIFIC CORP$135.7MBoston Scientific Cardio Award SPE2DE26D0010Materiality: 0.65% of $BSX revenue (Low)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. Here: $135.7M award ÷ $21.0B revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Sep 28, 2026LYRIC OPTICAL COMPANY$3.8MDLA Medical Equipment Electronic CATalog (ECAT) Generation V ProgramNo listed company matched (Materiality N/A)
• Aug 10, 2026BOSTON SCIENTIFIC NEUROMODULATION CORP$14.4MBoston Sci Neuromod Procedural PackagesMateriality: 0.07% of $BSX revenue (Low)How big this award is next to the company's revenue over the last 12 months: Low under 1%, Medium 1-5%, High 5% or more. Award amount divided by revenue from the company's SEC filings. Here: $14.4M award ÷ $21.0B revenue, 12 months to Jun 30, 2026 (SEC 10-Q). SEC
• Apr 15, 2026THE JANZ CORP$49.0MThe Janz Corp Medical Surgical ECAT ContractNo listed company matched (Materiality N/A)

Materiality: one award's value as a share of the winner's revenue over the latest 12 months in its SEC filings (or its last fiscal year, as noted when you point at it). Low under 1%, Medium 1 to 5%, High 5% or more. Many awards are paid over several years, so this overstates a single year's share.